List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 1016 studies with search of:   Norway
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
21 Completed Fast Titration Of Quetiapine Versus Currently Approved Titration
Condition: Psychotic Disorders
Intervention: Drug: Quetiapine
22 Completed Nexium Dyspepsia/AST
Conditions: Gastrointestinal Disease;   Signs and Symptoms, Digestive;   Dyspepsia
Intervention: Drug: Esomeprazole
23 Recruiting RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Conditions: Heart Failure;   Anemia;   Cardiovascular Disease;   Ventricular Dysfunction;   Congestive Heart Failure
Interventions: Drug: Darbepoetin alfa;   Drug: Placebo
24 Completed Survival Of Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition: Chronic Obstructive Pulmonary Disease (COPD)
Intervention: Drug: Salmeterol 50mcg/ Fluticasone Propionate 500mcg
25 Completed Evaluate Safety & Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults.
Condition: Influenza
Interventions: Biological: GSK Biologicals Influenza Vaccine GSK576389A;   Biological: Fluarix
26 Recruiting Study Of SB-683699 Compared To Placebo In Subjects With Relapsing-Remitting Multiple Sclerosis (MS)
Condition: Relapsing Remitting Multiple Sclerosis
Intervention: Drug: SB-683699
27 Completed An Open-Label Study of Adalimumab for the Induction and Maintenance of Clinical Remission in Subjects With Moderate to Severe Crohn's Disease
Condition: Crohn's Disease
Interventions: Biological: adalimumab;   Biological: adalimumab
28 Recruiting Comparison Between Transvaginal Mesh and Traditional Surgery for Pelvic Organ Prolapse
Condition: Vaginal Prolapse
Interventions: Procedure: Anterior colporrhaphy;   Procedure: Anterior PROLIFT
29 Completed Dabigatran Etexilate in Extended VTE Prevention After Hip Replacement Surgery
Conditions: Thromboembolism;   Arthroplasty, Replacement, Hip
Interventions: Drug: "Dabigatran etexilate (oral, 150 mg once daily)";   Drug: "Enoxaparin (subcutaneous, 40 mg once daily)";   Drug: "Dabigatran etexilate (oral, 220 mg once daily)"
30 Recruiting Study of an Investigational Drug for the Prevention of Thrombosis-Related Events Following Hip Replacement Surgery
Conditions: Deep Vein Thrombosis;   Pulmonary Embolism
Interventions: Drug: Enoxaparin + Placebo;   Drug: Apixaban + Placebo
31 Completed On Demand Treatment of Reflux Disease
Condition: Gastroesophageal Reflux
Interventions: Drug: Esomeprazole;   Drug: Pectin-containing nature product
32 Completed Alvimopan For The Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
Conditions: Bowel Dysfunction;   Constipation
Intervention: Drug: alvimopan
33 Not yet recruiting A Study To Assess Single Dosage Strength Of GW685698/GW642444 Chronic Obstructive Pulmonary Disease (COPD)
Condition: COPD
Intervention: Drug: GW685698/GW642444
34 Completed Postmenopausal Evaluation and Risk-Reduction With Lasofoxifene (PEARL)
Condition: Osteoporosis
Interventions: Drug: lasofoxifene;   Other: placebo;   Drug: lasofoxifene
35 Completed Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine for Overactive Bladder
Condition: Overactive Bladder
Interventions: Drug: fesoterodine fumarate;   Drug: placebo;   Drug: tolterodine tartrate
36 Completed Changes Following Inpatient Child-Oriented Family Treatment
Condition: Psychiatric Disorders
Interventions: Behavioral: Intensive family therapy - inpatient;   Behavioral: Diagnostic assessment - child and adolescent psychiatry
37 Active, not recruiting Nexium vs. Surgery
Condition: Gastroesophageal Reflux
Interventions: Drug: esomeprazole;   Procedure: Laparoscopic fundoplication (surgery)
38 Completed Esomeprazole for Relief of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs
Conditions: NSAIDs;   Upper GI Symptoms
Intervention: Drug: Esomeprazole
39 Completed A Clinical Trial Comparing the Efficacy and Safety of Exubera and Lantus
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Inhaled Human Insulin (Exubera);   Drug: Insulin Glargine (Lantus)
40 Active, not recruiting A Study to Determine the Optimal Protocol for Treatment Initiation With Methotrexate and Adalimumab Combination Therapy in Patients With Early Rheumatoid Arthritis - OPTIMA
Condition: Rheumatoid Arthritis
Interventions: Biological: Humira (adalimumab) + methotrexate;   Biological: Placebo + methotrexate

Previous Page (1-20) Studies Shown (21-40) Next (41-60)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services